These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 33687847)

  • 1. CoronaPep: An Anti-Coronavirus Peptide Generation Tool.
    Kaushik AC; Mehmood A; Selvaraj G; Dai X; Pan Y; Wei DQ
    IEEE/ACM Trans Comput Biol Bioinform; 2021; 18(4):1299-1304. PubMed ID: 33687847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 Proteins: Are They Useful as Targets for COVID-19 Drugs and Vaccines?
    Mohammed MEA
    Curr Mol Med; 2022; 22(1):50-66. PubMed ID: 33622224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural biology of SARS-CoV-2 and implications for therapeutic development.
    Yang H; Rao Z
    Nat Rev Microbiol; 2021 Nov; 19(11):685-700. PubMed ID: 34535791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of artificial intelligence and machine learning for COVID-19 drug discovery and vaccine design.
    Lv H; Shi L; Berkenpas JW; Dao FY; Zulfiqar H; Ding H; Zhang Y; Yang L; Cao R
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34410360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LUNAR :Drug Screening for Novel Coronavirus Based on Representation Learning Graph Convolutional Network.
    Zhou D; Peng S; Wei DQ; Zhong W; Dou Y; Xie X
    IEEE/ACM Trans Comput Biol Bioinform; 2021; 18(4):1290-1298. PubMed ID: 34081583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the COVID-19 Potential Targets: Big Challenges to Quest Specific Treatment.
    Roy H; Gummadi A; Nayak BS; Nandi S; Saxena AK
    Curr Top Med Chem; 2021; 21(15):1337-1359. PubMed ID: 34315369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico ADMET and molecular docking study on searching potential inhibitors from limonoids and triterpenoids for COVID-19.
    Vardhan S; Sahoo SK
    Comput Biol Med; 2020 Sep; 124():103936. PubMed ID: 32738628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systems Biology Approaches for Therapeutics Development Against COVID-19.
    Jaiswal S; Kumar M; Mandeep ; Sunita ; Singh Y; Shukla P
    Front Cell Infect Microbiol; 2020; 10():560240. PubMed ID: 33194800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SAveRUNNER: A network-based algorithm for drug repurposing and its application to COVID-19.
    Fiscon G; Conte F; Farina L; Paci P
    PLoS Comput Biol; 2021 Feb; 17(2):e1008686. PubMed ID: 33544720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Open Science Resources for the Mass Spectrometry-Based Analysis of SARS-CoV-2.
    Bittremieux W; Adams C; Laukens K; Dorrestein PC; Bandeira N
    J Proteome Res; 2021 Mar; 20(3):1464-1475. PubMed ID: 33605735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Broad-Spectrum Anti-coronavirus Vaccines and Therapeutics to Combat the Current COVID-19 Pandemic and Future Coronavirus Disease Outbreaks.
    Cao M; Su X; Jiang S
    Stem Cell Reports; 2021 Mar; 16(3):398-411. PubMed ID: 33691145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shotgun transcriptome, spatial omics, and isothermal profiling of SARS-CoV-2 infection reveals unique host responses, viral diversification, and drug interactions.
    Butler D; Mozsary C; Meydan C; Foox J; Rosiene J; Shaiber A; Danko D; Afshinnekoo E; MacKay M; Sedlazeck FJ; Ivanov NA; Sierra M; Pohle D; Zietz M; Gisladottir U; Ramlall V; Sholle ET; Schenck EJ; Westover CD; Hassan C; Ryon K; Young B; Bhattacharya C; Ng DL; Granados AC; Santos YA; Servellita V; Federman S; Ruggiero P; Fungtammasan A; Chin CS; Pearson NM; Langhorst BW; Tanner NA; Kim Y; Reeves JW; Hether TD; Warren SE; Bailey M; Gawrys J; Meleshko D; Xu D; Couto-Rodriguez M; Nagy-Szakal D; Barrows J; Wells H; O'Hara NB; Rosenfeld JA; Chen Y; Steel PAD; Shemesh AJ; Xiang J; Thierry-Mieg J; Thierry-Mieg D; Iftner A; Bezdan D; Sanchez E; Campion TR; Sipley J; Cong L; Craney A; Velu P; Melnick AM; Shapira S; Hajirasouliha I; Borczuk A; Iftner T; Salvatore M; Loda M; Westblade LF; Cushing M; Wu S; Levy S; Chiu C; Schwartz RE; Tatonetti N; Rennert H; Imielinski M; Mason CE
    Nat Commun; 2021 Mar; 12(1):1660. PubMed ID: 33712587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current approaches for target-specific drug discovery using natural compounds against SARS-CoV-2 infection.
    Khare P; Sahu U; Pandey SC; Samant M
    Virus Res; 2020 Dec; 290():198169. PubMed ID: 32979476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update.
    Anand U; Jakhmola S; Indari O; Jha HC; Chen ZS; Tripathi V; Pérez de la Lastra JM
    Front Immunol; 2021; 12():658519. PubMed ID: 34276652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How to redesign COVID vaccines so they protect against variants.
    Callaway E; Ledford H
    Nature; 2021 Feb; 590(7844):15-16. PubMed ID: 33514888
    [No Abstract]   [Full Text] [Related]  

  • 16. Computers and viral diseases. Preliminary bioinformatics studies on the design of a synthetic vaccine and a preventative peptidomimetic antagonist against the SARS-CoV-2 (2019-nCoV, COVID-19) coronavirus.
    Robson B
    Comput Biol Med; 2020 Apr; 119():103670. PubMed ID: 32209231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular screening of antimalarial, antiviral, anti-inflammatory and HIV protease inhibitors against spike glycoprotein of coronavirus.
    Prashantha CN; Gouthami K; Lavanya L; Bhavanam S; Jakhar A; Shakthiraju RG; Suraj V; Sahana KV; Sujana HS; Guruprasad NM; Ramachandra R
    J Mol Graph Model; 2021 Jan; 102():107769. PubMed ID: 33152616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting intra-viral conserved nucleocapsid (N) proteins as novel vaccines against SARS-CoVs.
    Thura M; Sng JXE; Ang KH; Li J; Gupta A; Hong JM; Hong CW; Zeng Q
    Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34519332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 Infection: New Molecular, Phylogenetic, and Pathogenetic Insights. Efficacy of Current Vaccines and the Potential Risk of Variants.
    Rotondo JC; Martini F; Maritati M; Mazziotta C; Di Mauro G; Lanzillotti C; Barp N; Gallerani A; Tognon M; Contini C
    Viruses; 2021 Aug; 13(9):. PubMed ID: 34578269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How glycobiology can help us treat and beat the COVID-19 pandemic.
    Lardone RD; Garay YC; Parodi P; de la Fuente S; Angeloni G; Bravo EO; Schmider AK; Irazoqui FJ
    J Biol Chem; 2021; 296():100375. PubMed ID: 33548227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.